Furthermore, the simultaneous inhibition of the Hedgehog signaling pathway and autophagy significantly reduced the activity of, and induced apoptosis in, BCR-ABL-positive CML cells, irrespective of whether they were sensitive or resistant to imatinib [42, 43]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.